Form 10-Q INFINITY PHARMACEUTICALS For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Infinity Pharma (INFI) Posts Surprise Q3 Profit
November 6, 2015 8:11 AM ESTInfinity Pharma (NASDAQ: INFI) reported Q3 EPS of $0.85, $1.48 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $90.7 million versus the consensus estimate of $24.85 million.
Revenue included a $75.2 million license fee associated with the $130 million milestone payment from AbbVie... More
